Ukraine Trade Data of Patient Imports Under HS Code 30

Lookup Ukraine trade data of patient imports under HS code 30. Check Ukraine import trading parters of patient

 
shipment icon

31 Shipments Records (Demo)

30  
DateHS CodeProduct DescriptionOrigin CountryQuantityUnitNet WeightTotal Value [USD] Importer Name
28/Apr/201730042000001.veterynarnyy granulate preparation monenzyn 20%, for the treatment of coccidiosis in chickens patients posed eymeriyamy: eimeria tenella, e necatrix, e maxima, e miyati, e brunetty, e mittis, e praecox and other types eymeriy chickens.�pharmacological properties: atcvet qp51, anti veterinary medicine.�monenzyn natriyunalezhyt ionomorfnyh to a group of antibiotics.�the mechanism of action of the drug is in violation of cations transport of sodium and potassium in the oocysts that leads to death eymeriy the stage shyzohoniyi.rozfasovano 400 paper bags.�used for own needs for production.�.CHINA******UA12526010,00037,500.00 ***** 16 More Columns Available along with Company Name and Other Details etc.
28/Apr/20173004900000"1. goods supplied by the budget program 2301400: medicinal products for the treatment of patients with chronic myeloid leukemia - art.796857 neopaks tablets, film coated shell, 100 mg 10 tablets in a blister, 12 blisters in kart.korob. from ukrainian label movoyu.mizhnarodna inn "" imatinib "" total - 3152 package. per pack of 120 tablets (378, 240 tablets) series: v09258, v09259, v09269, v09270, v09271 - 3070 packages exp.data: 08/2019 ( 368, 400 tablets) series: v09227 - 82 package exp.data: 12/2019 (9840 tablets) active ingredients composition: 1 tablet covered with film�s shell contains 100 mg imatinib (as imatinib mesylate) registration certificate: ua / 14939/01 / 01torhovelna brand: neopaksvyrobnyk intas pharmaceuticals limited (manufacturer responsible for producing "" in bulk "", primary and secondary packaging) indiyakrka, dd, novo mesto (manufacturer responsible for secondary packaging, the manufacturer responsible for batch control, batch release) sloveniyazayavnyk: krka, dd, novo mesto, slovenia - art.796858 neopakstabletky coated film membrane 400 10 mg tablets in a blister;�6 blisters in a cardboard label korobtsiz ukrainian movoyu.mizhnarodna inn "" imatinib "" total - 570 package.�60 tablets per pack, (34, 200 tablets) series: v09207 - 432 package exp.data: 05/2019 (25920 tablets) series: v09221 - 129 package exp.data: 06/2019 (7740 tablets) series: v09228 - 9 packaging exp.data: 12/2019 (540 tablets) composition of active substances: 1 tablet covered with film wrapper contains 400 mg of imatinib (imatinib mesylate in a) registration certificate: ua / 14939/01 / 02torhovelna brand: neopaksvyrobnyk intas pharmaceuticals limited (producer responsible for the production of "" in bulk "", primary and secondary packaging) indiyakrka, dd, novo mesto (manufacturer responsible for secondary packaging, in�robnyk responsible for batch control, batch release) sloveniyazayavnyk: krka, dd, novo mesto, slovenia "SLOVENIA******UA100070395.52197,466.00 *****
27/Apr/201730063000001. pharmaceutical products to people, contrast agents for x-ray examinations (diagnostic reagents dlyavvedennya patients): omniskan, injection 0, 5mmol / ml in 10 ml vial 10 vials ukartonniy box series 13468891 - 43up. (active substances - 1ml mistythadodiamidu solution 287mh)) trademark: omniskankrayina production: ievyrobnyk: dzhyi helskea ireland.N/A******UA12503017.039,401.57 *****
27/Apr/201730063000001.farmatsevtychni products for people (kontrasni preparations for x-ray examinations to enter patients): 1.0 hadovist, injection, 1mmol / ml, in 7, 5ml syringe glass embedded in a plastic bag, sealed paper 5 syringe in a carton korobtsi.seriya 71140k-1000up. (active substance: 1 ml solution for injection contains: 604, 72mh hadobutrolu (equivalent to 1mmol / ml) trademark: bayerkrayina production: nimechchynavyrobnyk: bayer pharma ag.GERMANY******UA12503025163,447.59 *****
27/Apr/201730063000001.farmatsevtychni products for people (kontrasni preparations for x-ray examinations to enter patients): 1.0 hadovist, injection, 1mmol / ml, 5 ml syringe with glass embedded in a plastic bag, sealed paper, 5 syringes carton korobtsi.seriya 71064g-300up. (active substance: 1 ml solution for injection contains: 604, 72mh hadobutrolu (equivalent to 1mmol / ml) trademark: bayerkrayina production: nimechchynavyrobnyk: bayer pharma ag.GERMANY******UA12503069.3018,346.02 *****
27/Apr/201730042000001. veterinary medicinal products containing other antibiotics, put up for retail sale: -denagard 80% 25kg, (denahard (r) 80%) in powder form for oral use - to treat fever patients with dysentery, colitis, ileitis, enzootic pneumonia caused by pathogens susceptible to tiamulinu.�the polyethylene barrel to 25kg.�1 g of the drug contains the active substance: tiamulin hydrogen fumarate - 800 mg.�excipients: zhelatyn.seriya: v270765-9 pack.�limited time fit .: 09.2017.�trademark - novartis.krayina production - at.vyrobnyk - sandoz gmbh, plant shafteno.�.AUSTRIA******UA1000102252,357.10 *****
27/Apr/201730042000001. veterinary medicinal products containing other antibiotics, put up for retail sale: -denagard 10% inj 100ml, (denahard (r) 10% injection) in the form of injection - to treat fever patients dysentery, enzootic pneumonia, pleuropneumonia, arthritis, caused by pathogens susceptible to tiamulinu.�bottles made of glass, closed rubber stopper under an aluminum run of 100 ml (№1).�active ingredients: 1 ml contains the active substance: tiamulin hydrogen fumarate - 123 mg.�series: 09pn1190-200 pack.�shelf life: 09.2019.�trademark - novartis.krayina production - at.vyrobnyk - sanohemiya pharmaceutics ag.�.AUSTRIA******UA10001031964.00 *****
26/Apr/201730049000001. registered medicines for people and videogram prize, to be used exclusively for klinichnohodoslidzhennya protocol: hp-3070-gl-04.�preparations non-drug means psyhotropnyhrechovyn and precursors.�not for sale.�a randomized, double-blind, placebo-kontralovane with the use of fixed-dose 6-week study in 30 patients with shyzofreniyeyu.- patches of drug nc-3070 // 9 ml or placebo transdermal use - 100 sht.seriya №: 211042 / 5 (lot # asp15108 to 9mg, asp14215 placebo) expiry date: 31/11 / 2017vyrobnyk: hisamitsu pharmaceutical, r & d division (japan) net weight: 0.148 * 100 = 14.8kh.�.JAPAN******UA12510014.806,787.30 *****
21/Apr/201730049000001. registered medicines for people and videogram prize, to be used exclusively for klinichnohodoslidzhennya protocol: ged-0301-cd-004.�preparations non-drug means psyhotropnyhrechovyn and precursors.�not for sale.�"a double-blind, randomized, placebo-controlled, multicenter phase 3 study to examine the efficacy and safety of the drug monhersen (ged-0301) for treatment-tion of patients with crohn's disease in the active formi.- ged-0301 (monhersen) tablets 40mg or placebo 124 tablets in blister - 30 blisteriv.protokol study: ged-0301-cd-004 series packing number: 16f2757, 16r0239partiya number: vsmz, vhtk, whdb, and wkss0.226kh's 30sht = 6.79 kg.�.N/A******UA1251006.7965,990.20 *****
20/Apr/201730049000001.liky code for clinical trials research canuti-7: set patient -kanefron h (clr) (centaury grass 18mh / lovage root 18mh / lystyarozmarynu 18mh) or placebo table w / obol blist №24h2 + fosfomycin trometanol 3habo 8g placebo granules in sachets №1 - 8naboriv trade mark: bionorica sevyrobnyk: bionorica se, svittserland zambon co., temmler pharma gmbh kokrayina end production: de.GERMANY******UA1002400.4085.80 *****
12345...90NextGoTo:
Need to access complete data?
loading icon

Get global trade data online at your fingertips

  
TERMS & CONDITIONS     |    CANCELATION POLICY     |    REFUND POLICY     |     PRIVACY POLICY
Copyright © 2021 Export Genius. All rights reserved